Evaluating Different Perspectives in Gastric Cancer Treatment

Published:

As the changing living standards & improper dietary habits of the people are introducing new diseases, cancers are not uncommon but becoming highly prevalent. Just like that, gastric cancer is affecting a substantial population throughout the world and is becoming a prominent cause of death in people.

More people are developing gastric cancer, commonly known as stomach cancer, as a result of rising obesity & smoking rates. The risks associated with these cancers are increased by smoking & poor eating habits, where the stomach lining develops malignant cells.

Some signs & symptoms of stomach cancer are bloating, nausea, unexplained weight loss, indigestion, vomiting, heartburn, and trouble swallowing. This type of cancer can affect any portion of the stomach, although the esophagus is most frequently affected. Observing the high prevalence of these diseases, a recent research report published by MarkNtel Advisors reveals that the Global Gastric Cancer Market is set to register a CAGR of around 14.80% during 2022-27. Now let us take a deeper dive into understanding gastric cancer & its potential treatment options in the future.

The Mounting Prevalence of Gastric Cancer Worldwide

Over the years, research & development to find more reliable & effective therapeutics for treating or relieving people with gastric cancers have eased numerous patients globally. The stage or phase of the disease at the time of diagnosis significantly impacts the stomach cancer survival rate. Besides, with the rising health awareness among people entwined with the active participation of the governments & leading players through investments, research & development activities, and the presence of favorable policies for the clinical trials of therapeutics, the potential of this industry is significant in the coming years.

Additionally, as people are becoming more aware of the availability & effectiveness of the diagnosis & treatment for gastric cancer, the number of screening tests is increasing swiftly throughout the globe. It has prompted the top biopharma companies to expand their distribution and production capabilities to meet the growing demand from patients for treatment.

Moreover, the growing focus of numerous companies on R&D initiatives to discover novel treatments for stomach cancer & improve currently available therapies are also fueling the overall industry and demonstrating a rise in several mergers & acquisitions among well-known firms to expand their product offerings and reach.

There are different types of therapeutics used in addressing gastric cancer, like surgery, targeted drug therapy, chemotherapy, etc. Here, surgery is the most commonly practiced treatment for the illness owing to its capability to treat malignancies of all stages.

The most prominent Chemotherapy drugs used for gastric cancer treatment include:

  • 5-FU (fluorouracil) given with leucovorin (folinic acid)
  • Carboplatin
  • Cisplatin
  • Epirubicin
  • Oxaliplatin
  • Capecitabine
  • Paclitaxel
  • Docetaxel
  • Irinotecan

High Treatment Costs & Insufficient Financial Support

Since certain diagnoses & therapies of most cancers, including gastric cancer, incur high costs, it limits the number of patients opting for treatments due to their inability to afford them. Besides, some people also find difficulties attaining financial support from various health insurance companies due to rigid policies. These aspects are acting as prominent growth restraints for the Global Gastric Cancer Market.

Future Horizons in Gastric Cancer Therapeutics

Backed by the significant investments by the governments of different countries globally in numerous research & development activities to bring more reliable & effective treatment for stomach cancer, the overall potential of the industry is opportunistic. Moreover, supportive regulations for medication clinical trials shall also have a positive influence on the expansion over the forecast years.

Considering all the aspects cited above in the blog, we can conclude that the future of this industry is profitable for the leading players and shall generate opportunities for them to bring new therapeutics and indulge in the industry, and cater to the needs of the massive patient pool globally. These aspects shall further lead the industry toward substantial growth during the forecast period.

Source: – Evaluating Different Perspectives in Gastric Cancer Treatment

Related Articles

Related articles

Recent articles